BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34893145)

  • 21. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
    Patil P; Cieslak A; Bernhart SH; Toprak UH; Wagener R; López C; Wiehle L; Bens S; Altmüller J; Franitza M; Scholz I; Jayne S; Ahearne MJ; Scheffold A; Jebaraj BMC; Schneider C; Costa D; Braun T; Schrader A; Campo E; Dyer MJS; Nürnberg P; Dürig J; Johansson P; Böttcher S; Schlesner M; Herling M; Stilgenbauer S; Macintyre E; Siebert R
    Genes Chromosomes Cancer; 2020 Apr; 59(4):261-267. PubMed ID: 31677197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
    Frater JL
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():90-98. PubMed ID: 32543075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
    Sun S; Fang W
    Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
    Johansson P; Klein-Hitpass L; Choidas A; Habenberger P; Mahboubi B; Kim B; Bergmann A; Scholtysik R; Brauser M; Lollies A; Siebert R; Zenz T; Dührsen U; Küppers R; Dürig J
    Blood Cancer J; 2018 Jan; 8(1):11. PubMed ID: 29352181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia.
    Tian S; Zhang H; Zhang P; Kalmbach M; Lee JH; Ordog T; Hampel PJ; Call TG; Witzig TE; Kay NE; Klee EW; Slager SL; Yan H; Ding W
    Sci Rep; 2021 Apr; 11(1):8318. PubMed ID: 33859327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
    Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
    Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
    Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
    Kiel MJ; Velusamy T; Rolland D; Sahasrabuddhe AA; Chung F; Bailey NG; Schrader A; Li B; Li JZ; Ozel AB; Betz BL; Miranda RN; Medeiros LJ; Zhao L; Herling M; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Aug; 124(9):1460-72. PubMed ID: 24825865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
    Hu Z; Li S; Medeiros LJ; Sun T
    Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
    Cao TM; Coutre SE
    Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous presentation of T-cell prolymphocytic leukemia.
    Ventre MO; Bacelieri RE; Lazarchick J; Pollack RB; Metcalf JS
    Cutis; 2013 Feb; 91(2):87-91. PubMed ID: 23513557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.
    Yoshioka Y; Nagao M; Saitoh T; Yoshioka S; Tsunemine H; Itoh K; Kodaka T; Takahashi T
    J Clin Exp Hematop; 2015; 55(1):17-21. PubMed ID: 26106002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.
    Das DK; Pathan SK; Joneja M; Al-Musawi FA; John B; Mirza KR
    Diagn Cytopathol; 2013 Apr; 41(4):360-5. PubMed ID: 21987484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell prolymphocytic leukemia: a report of two cases with review of literature.
    Naseem S; Gupta R; Kashyap R; Nityanand S
    Indian J Hematol Blood Transfus; 2008 Dec; 24(4):178-81. PubMed ID: 23100959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.
    Garand R; Goasguen J; Brizard A; Buisine J; Charpentier A; Claisse JF; Duchayne E; Lagrange M; Segonds C; Troussard X; Flandrin G
    Br J Haematol; 1998 Nov; 103(2):488-94. PubMed ID: 9827924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lymphatic leukemias of T and NK cell type.
    Kingreen D; Siegert W
    Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.
    Dearden CE; Matutes E; Cazin B; Tjønnfjord GE; Parreira A; Nomdedeu B; Leoni P; Clark FJ; Radia D; Rassam SM; Roques T; Ketterer N; Brito-Babapulle V; Dyer MJ; Catovsky D
    Blood; 2001 Sep; 98(6):1721-6. PubMed ID: 11535503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemia.
    Johansson P; Klein-Hitpass L; Röth A; Möllmann M; Reinhardt HC; Dührsen U; Dürig J
    Eur J Haematol; 2020 Dec; 105(6):786-796. PubMed ID: 32875608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
    Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
    Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.